Your browser doesn't support javascript.
Transcatheter aortic valve implantation amid the COVID-19 pandemic: a nationwide analysis of the first COVID-19 wave in the Netherlands.
Rooijakkers, M J P; Li, W W L; Stens, N A; Vis, M M; Tonino, P A L; Timmers, L; Van Mieghem, N M; den Heijer, P; Kats, S; Stella, P R; Roolvink, V; van der Werf, H W; Stoel, M G; Schotborgh, C E; Amoroso, G; Porta, F; van der Kley, F; van Wely, M H; Gehlmann, H; van Garsse, L A F M; Geuzebroek, G S C; Verkroost, M W A; Mourisse, J M; Medendorp, N M; van Royen, N.
  • Rooijakkers MJP; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Li WWL; Department of Cardiothoracic Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Stens NA; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Vis MM; Department of Physiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Tonino PAL; Department of Cardiology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • Timmers L; Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.
  • Van Mieghem NM; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • den Heijer P; Department of Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Kats S; Department of Cardiology, Amphia Hospital, Breda, The Netherlands.
  • Stella PR; Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Roolvink V; Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • van der Werf HW; Department of Cardiology, Isala Hospital, Zwolle, The Netherlands.
  • Stoel MG; Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Schotborgh CE; Department of Cardiology, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Amoroso G; Department of Cardiology, Haga Hospital, The Hague, The Netherlands.
  • Porta F; Department of Cardiology, OLVG Hospital, Amsterdam, The Netherlands.
  • van der Kley F; Department of Cardiothoracic Surgery, Leeuwarden Medical Centre, Leeuwarden, The Netherlands.
  • van Wely MH; Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Gehlmann H; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • van Garsse LAFM; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Geuzebroek GSC; Department of Cardiothoracic Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Verkroost MWA; Department of Cardiothoracic Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Mourisse JM; Department of Cardiothoracic Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Medendorp NM; Department of Anaesthesiology, Pain and Palliative Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • van Royen N; Netherlands Heart Registration, Utrecht, The Netherlands.
Neth Heart J ; 30(11): 503-509, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-1872740
ABSTRACT

INTRODUCTION:

The coronavirus disease 2019 (COVID-19) pandemic has put tremendous pressure on healthcare systems. Most transcatheter aortic valve implantation (TAVI) centres have adopted different triage systems and procedural strategies to serve highest-risk patients first and to minimise the burden on hospital logistics and personnel. We therefore assessed the impact of the COVID-19 pandemic on patient selection, type of anaesthesia and outcomes after TAVI.

METHODS:

We used data from the Netherlands Heart Registration to examine all patients who underwent TAVI between March 2020 and July 2020 (COVID cohort), and between March 2019 and July 2019 (pre-COVID cohort). We compared patient characteristics, procedural characteristics and clinical outcomes.

RESULTS:

We examined 2131 patients who underwent TAVI (1020 patients in COVID cohort, 1111 patients in pre-COVID cohort). EuroSCORE II was comparable between cohorts (COVID 4.5 ± 4.0 vs pre-COVID 4.6 ± 4.2, p = 0.356). The number of TAVI procedures under general anaesthesia was lower in the COVID cohort (35.2% vs 46.5%, p < 0.001). Incidences of stroke (COVID 2.7% vs pre-COVID 1.7%, p = 0.134), major vascular complications (2.3% vs 3.4%, p = 0.170) and permanent pacemaker implantation (10.0% vs 9.4%, p = 0.634) did not differ between cohorts. Thirty-day and 150-day mortality were comparable (2.8% vs 2.2%, p = 0.359 and 5.2% vs 5.2%, p = 0.993, respectively).

CONCLUSIONS:

During the COVID-19 pandemic, patient characteristics and outcomes after TAVI were not different than before the pandemic. This highlights the fact that TAVI procedures can be safely performed during the COVID-19 pandemic, without an increased risk of complications or mortality.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Neth Heart J Year: 2022 Document Type: Article Affiliation country: S12471-022-01704-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Neth Heart J Year: 2022 Document Type: Article Affiliation country: S12471-022-01704-9